A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Cherny, N.I., Sullivan, R., Dafni, U., Kerst, J.M., Sobrero, A., Zielinski, C., de Vries, E.G.E., Piccart, M.J.
Published in Annals of oncology (01.08.2015)
Published in Annals of oncology (01.08.2015)
Get full text
Journal Article
ESMO-Magnitude of Clinical Benefit Scale version 1.1
Cherny, N.I., Dafni, U., Bogaerts, J., Latino, N.J., Pentheroudakis, G., Douillard, J.-Y., Tabernero, J., Zielinski, C., Piccart, M.J., de Vries, E.G.E.
Published in Annals of oncology (01.10.2017)
Published in Annals of oncology (01.10.2017)
Get full text
Journal Article
A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
Popat, S., Curioni-Fontecedro, A., Dafni, U., Shah, R., O'Brien, M., Pope, A., Fisher, P., Spicer, J., Roy, A., Gilligan, D., Gautschi, O., Nadal, E., Janthur, W.D., López Castro, R., García Campelo, R., Rusakiewicz, S., Letovanec, I., Polydoropoulou, V., Roschitzki-Voser, H., Ruepp, B., Gasca-Ruchti, A., Peters, S., Stahel, R.A.
Published in Annals of oncology (01.12.2020)
Published in Annals of oncology (01.12.2020)
Get full text
Journal Article
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
Dafni, U, Michielin, O, Lluesma, S Martin, Tsourti, Z, Polydoropoulou, V, Karlis, D, Besser, M J, Haanen, J, Svane, I -M, Ohashi, P S, Kammula, U S, Orcurto, A, Zimmermann, S, Trueb, L, Klebanoff, C A, Lotze, M T, Kandalaft, L E, Coukos, G
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data
Pérol, M., Felip, E., Dafni, U., Polito, L., Pal, N., Tsourti, Z., Ton, T.G.N., Merritt, D., Morris, S., Stahel, R., Peters, S.
Published in Annals of oncology (01.05.2022)
Published in Annals of oncology (01.05.2022)
Get full text
Journal Article
Gender medicine and oncology: report and consensus of an ESMO workshop
Wagner, A.D., Oertelt-Prigione, S., Adjei, A., Buclin, T., Cristina, V., Csajka, C., Coukos, G., Dafni, U., Dotto, G.-P., Ducreux, M., Fellay, J., Haanen, J., Hocquelet, A., Klinge, I., Lemmens, V., Letsch, A., Mauer, M., Moehler, M., Peters, S., Özdemir, B.C.
Published in Annals of oncology (01.12.2019)
Published in Annals of oncology (01.12.2019)
Get full text
Journal Article
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
Coleman, R, Powles, T, Paterson, A, Gnant, M, Anderson, S, Diel, I, Gralow, J, von Minckwitz, G, Moebus, V, Bergh, J, Pritchard, KI, Bliss, J, Cameron, D, Evans, V, Pan, H, Peto, R, Bradley, R, Gray, R, Bartsch, R, Dubsky, P, Fesl, C, Fohler, H, Greil, R, Jakesz, R, Lang, A, Luschin-Ebengreuth, G, Marth, C, Mlineritsch, B, Samonigg, H, Singer, CF, Steger, GG, Stoger, H, Olivotto, I, Ragaz, J, Christiansen, P, Ejlertsen, B, Ewertz, M, Jensen, MB, Moller, S, Mouridsen, HT, Eiermann, W, Hilfrich, J, Jonat, W, Kaufmann, M, Kreienberg, R, Schumacher, M, Blohmer, JU, Costa, SD, Eidtmann, H, Gerber, B, Jackisch, C, Loibl, S, Dafni, U, Markopoulos, C, Blomqvist, C, Saarto, T, Ahn, JH, Jung, KH, Perrone, F, Bass, G, Brown, A, Bryant, J, Costantino, J, Dignam, J, Fisher, B, Geyer, C, Mamounas, EP, Paik, S, Redmond, C, Swain, S, Wickerham, L, Wolmark, N, Perez, E, Ingle, JN, Suman, VJ, Hadji, P, A'Hern, R, Dowsett, M, Makris, A, Parton, M, Pennert, K, Powles, TJ, Smith, IE, Yarnold, JR, Clack, G, Van Poznak, C, Safra, T, Bell, R, Coleman, RE, Dodwell, D, Hinsley, S, Marshall, HC, Solomayer, E, Fehm, T, Lester, J, Winter, MC, Horsman, JM, Aft, R, Brufsky, AM, Llombart, HA
Published in The Lancet (British edition) (03.10.2015)
Published in The Lancet (British edition) (03.10.2015)
Get full text
Journal Article
Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer—The ETOP NICOLAS trial
Peters, S., Felip, E., Dafni, U., Belka, C., Guckenberger, M., Irigoyen, A., Nadal, E., Becker, A., Vees, H., Pless, M., Martinez-Marti, A., Tufman, A., Lambrecht, M., Andratschke, N., Piguet, A.C., Kassapian, M., Roschitzki-Voser, H., Rabaglio-Poretti, M., Stahel, R.A., Vansteenkiste, J., De Ruysscher, D.
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2019)
Published in Lung cancer (Amsterdam, Netherlands) (01.07.2019)
Get full text
Journal Article
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
Martín-Lluesma, S., Svane, I.M., Dafni, U., Vervita, K., Karlis, D., Dimopoulou, G., Tsourti, Z., Rohaan, M.W., Haanen, J.B.A.G., Coukos, G.
Published in Annals of oncology (01.10.2024)
Published in Annals of oncology (01.10.2024)
Get full text
Journal Article
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
Castelo-Branco, L., Pellat, A., Martins-Branco, D., Valachis, A., Derksen, J.W.G., Suijkerbuijk, K.P.M., Dafni, U., Dellaporta, T., Vogel, A., Prelaj, A., Groenwold, R.H.H., Martins, H., Stahel, R., Bliss, J., Kather, J., Ribelles, N., Perrone, F., Hall, P.S., Dienstmann, R., Booth, C.M., Pentheroudakis, G., Delaloge, S., Koopman, M.
Published in Annals of oncology (01.12.2023)
Published in Annals of oncology (01.12.2023)
Get full text
Journal Article
Position of a panel of international lung cancer experts on the approval decision for use of durvalumab in stage III non-small-cell lung cancer (NSCLC) by the Committee for Medicinal Products for Human Use (CHMP)
Peters, S., Dafni, U., Boyer, M., De Ruysscher, D., Faivre-Finn, C., Felip, E., Garrido, P., Girard, N., Guckenberger, M., Haanen, J., Le Pechoux, C., Mornex, F., Ozsahin, M., Paz-Ares, L., Planchard, D., Raben, D., Ramalingam, S., Reck, M., Smit, E., Stahel, R., Stenzinger, A., Swanton, C., Vallone, S., Garassino, M.C.
Published in Annals of oncology (01.02.2019)
Published in Annals of oncology (01.02.2019)
Get full text
Journal Article
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)
Cherny, N I, Sullivan, R, Dafni, U, Kerst, J M, Sobrero, A, Zielinski, C, de Vries, E G E, Piccart, M J
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0
Kiesewetter, B., Dafni, U., de Vries, E.G.E., Barriuso, J., Curigliano, G., González-Calle, V., Galotti, M., Gyawali, B., Huntly, B.J.P., Jäger, U., Latino, N.J., Malcovati, L., Oosting, S.F., Ossenkoppele, G., Piccart, M., Raderer, M., Scarfò, L., Trapani, D., Zielinski, C.C., Wester, R., Zygoura, P., Macintyre, E., Cherny, N.I.
Published in Annals of oncology (01.09.2023)
Published in Annals of oncology (01.09.2023)
Get full text
Journal Article
Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
Lazor-Blanchet, C., Zygoura, P., Dafni, U., Lamoth, F., Tsourti, Z., Lobritz, M.A., Regina, J., Grandbastien, B., Fenwick, C., Pantaleo, G., Calandra, T., Meylan, S.
Published in The Journal of infection (01.05.2022)
Published in The Journal of infection (01.05.2022)
Get full text
Journal Article
Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)
Bamias, A., Dafni, U., Karadimou, A., Timotheadou, E., Aravantinos, G., Psyrri, A., Xanthakis, I., Tsiatas, M., Koutoulidis, V., Constantinidis, C., Hatzimouratidis, C., Samantas, E., Visvikis, A., Chrisophos, M., Stravodimos, K., Deliveliotis, C., Eleftheraki, A., Pectasides, D., Fountzilas, G., Dimopoulos, M.A.
Published in Annals of oncology (01.04.2013)
Published in Annals of oncology (01.04.2013)
Get full text
Journal Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
Gyawali, B., de Vries, E.G.E., Dafni, U., Amaral, T., Barriuso, J., Bogaerts, J., Calles, A., Curigliano, G., Gomez-Roca, C., Kiesewetter, B., Oosting, S., Passaro, A., Pentheroudakis, G., Piccart, M., Roitberg, F., Tabernero, J., Tarazona, N., Trapani, D., Wester, R., Zarkavelis, G., Zielinski, C., Zygoura, P., Cherny, N.I.
Published in ESMO open (01.06.2021)
Published in ESMO open (01.06.2021)
Get full text
Journal Article
Survival outcome of non-small cell lung cancer patients: Comparing results between the database of the Comprehensive Cancer Center Zürich and the Epidemiological Cancer Registry Zurich and Zug
Stahel, R.A., Curioni-Fontecedro, A., Rohrmann, S., Dafni, U., Sandner, U., Opitz, I., Andratschke, N., Franzen, D., Dimopoulou, G., Matthes, K.L., Kohler, M., Guckenberger, M., Weder, W.
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Published in Lung cancer (Amsterdam, Netherlands) (01.08.2020)
Get full text
Journal Article
Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project
Kerr, K.M., Dafni, U., Schulze, K., Thunnissen, E., Bubendorf, L., Hager, H., Finn, S., Biernat, W., Vliegen, L., Losa, J.H., Marchetti, A., Cheney, R., Warth, A., Speel, E.-J., Blackhall, F., Monkhorst, K., Jantus Lewintre, E., Tischler, V., Clark, C., Bertran-Alamillo, J., Meldgaard, P., Gately, K., Wrona, A., Vandenberghe, P., Felip, E., De Luca, G., Savic, S., Muley, T., Smit, E.F., Dingemans, A.-M.C., Priest, L., Baas, P., Camps, C., Weder, W., Polydoropoulou, V., Geiger, T.R., Kammler, R., Sumiyoshi, T., Molina, M.A., Shames, D.S., Stahel, R.A., Peters, S.
Published in Annals of oncology (01.01.2018)
Published in Annals of oncology (01.01.2018)
Get full text
Journal Article
Correcetions to “A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)”
Cherny, N.I., Sullivan, R., Dafni, U., Kerst, J.M., Sobrero, A., Zielinski, C., de Vries, E.G.E., Piccart, M.J.
Published in Annals of oncology (01.11.2017)
Published in Annals of oncology (01.11.2017)
Get full text
Journal Article
Proton pump inhibitors negatively impact survival of PD-1 inhibitor based therapies in metastatic melanoma patients
Homicsko, K., Richtig, G., Tuchmann, F., Tsourti, Z., Hanahan, D., Coukos, G., Wind-Rotolo, M., Richtig, E., Zygoura, P., Holler, C., Dafni, U., Michielin, O.A.
Published in Annals of oncology (01.12.2018)
Published in Annals of oncology (01.12.2018)
Get full text
Journal Article